GC2302 Study Site 104 is a clinical research site located in Asheville, North Carolina, United States 28803.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
GC2302 Study Site 104 has participated in 1 clinical trials.
Therapeutic areas: Dry Eye Disease.
Sponsors: Instituto Grifols, S.A..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Asheville
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GC2302 Study Site 104 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GC2302 Study Site 104 has 1 clinical trials on record. Their work covers Dry Eye Disease.
GC2302 Study Site 104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.